Delivery Order SPE2DB22D1106-SPE2DB25FDHP1

Award Date 10/18/24
Potential Completion Date 11/8/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ANDEXXA 200 MG VIALS to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $8,391.55. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, is a delivery order valued at $16,783.10 for the supply of ANDEXXA 200 MG VIALS. The contract is a firm fixed price award issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. Amerisourcebergen Drug Corp is the prime contractor and this award is not associated with any set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division for the delivery of 4564433758 ANDEXXA 200 MG VIALS. The contract has a firm fixed price ceiling value of $33,293.65 and a completion date of May 20, 2024. This is a delivery order contract type with no set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, has been awarded this order as part of its Indefinite Delivery...
This federal contract award, valued at $13,863.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ANDEXXA 200 MG VIALS, a specialized medical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
This federal contract award, valued at $8,672.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,888.85, is for the delivery of 4566586927 ANDEXXA 200MG VIALS 4S. This is a Firm Fixed Price Delivery Order contract with a performance period through December 4, 2024. The contract is not designated with a set-aside requirement. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ANDEXXA 200 MG VIALS, a specialty medication, at a firm fixed price of $27,555.40. The contract has an ultimate completion date of December 13, 2024 and was awarded on November 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. federal government awarded a delivery order contract valued at $6,658.72 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the supply of ANDEXXA 200 MG VIALS, a pharmaceutical product. This contract is not set aside for any particular business type. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
The federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $56,402.41 Firm Fixed Price delivery order, with an ultimate completion date of October 21, 2024, is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $16,855.40 firm-fixed-price delivery order, with a completion date of December 6, 2024, is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDHP1
    Delivery Order

This federal contract award is for the delivery of ANDEXXA 200 MG VIALS to the Defense Logistics Agency (DLA). The $16,783.10 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 8, 2024 and was awarded on October 18, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 1/17/25, 9:24 AM